All Posts
De's 0.9 Mile Marathon Celebrates Community
On Saturday, June 1st, 2024, the streets of Baltimore, Maryland, came alive with celebration and remembrance as the second annual…
A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors
Study Name A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors…
The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer
The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 18th at Midnight Oil…
A Phase I, Dose Escalation Safety and Tolerability Study of VAXINIA (CF33-hNIS), Administered Intratumorally or Intravenously as a Monotherapy or in Combination with Pembrolizumab in Adult Patients with Metastatic or Advanced Solid Tumors (MAST).
Study Name A Phase I, Dose Escalation Safety and Tolerability Study of VAXINIA (CF33-hNIS), Administered Intratumorally or Intravenously as a Monotherapy…
Honoring A Legacy: The Laura Dye Tie Challenge at American Preparatory Academy
WEST VALLEY CITY, UTAH - The American Preparatory Academy-West Valley 1 campus in West Valley City came together to honor…
The Fifth Annual Quack Out Cholangio 5K Run/Walk Raises Funds for Rare Cancer Research
NEWARK, DELAWARE – The 5th Annual Quack Out Cholangio 5k Run/Walk to Crush Bile Duct Cancer was held May 18th…
Honoring a Friend: Seth Weiner’s Fundraising Hike for Cholangiocarcinoma
Seth Weiner lost his longtime friend, Mark Kinsley, to cholangiocarcinoma. Seth transformed his annual 50k “One Day Hike” into a…
Shannon Volkov, CCA Caregiver
A Profound Experience as a CaregiverShannon Volkov's journey as a caregiver for her mother, who was diagnosed with cholangiocarcinoma in…
ThrashElvania Wrestling Event Raises Funds and Awareness
In a poignant tribute to his late wife, Megan Thrash, Kevin McElvaney, Editor-in-Chief of Pro Wrestling Illustrated, hosted the ThrashElvania…
Cholangiocarcinoma Foundation Awards $250,000 Innovation Grant to Advance Rare Cancer Research with Funding from Bachrach Family Foundation
The Cholangiocarcinoma Foundation announced the recipients of the 2024 Innovation Grant, generously funded by the Bachrach Family Foundation. The Cholangiocarcinoma…